LAUREN MAYLE: Open Payments
NPI 1205330909 · MORGANTOWN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$169 in 10 payments from 7 companies in 2025. Trend: 2023 $87 · 2024 $221 · 2025 $169
Food & beverage: $169
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Eisai Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: INGREZZA, TRINTELLIX, ABILIFY ASIMTUFII, Leqembi, UBRELVY, REXULTI, CAPLYTA, INVEGA SUSTENNA.
Industry payments across WV — which companies pay providers there.
